Chemical Structure (Oraqix 01)
Oraqix Gel
Product Images NDC 66312-110
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oraqix (NDC 66312-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Dentsply Pharmaceutical, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Oraqix 02
Oraqix 03
Product: Oraqix® gel is a combination of lidocaine and prilocaine used for periodontal treatment. The package contains 20 cartridges, each with 2.5% lidocaine and 2.5% prilocaine. The product is not intended for injection. The manufacturer details are as follows: Dentsply NDC 66312-110-20, Sirona Reorder #: 6631211020.*
Oraqix 04
This text appears to be a combination of errors and technical terms related to a medical device called Oragix Dispenser, which is indicated for the administration of local anesthetics such as lidocaine and prilocaine for periodontal use. The text mentions that the dispenser is not suitable for passive or active aspiration and highlights the risk of inadvertent intravascular injections. It also advises checking the package insert for complete instructions.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
